Surgery Websites
Thoracic Oncology Program »  Meet the Team »  Pulmonologists »  Lorriana Leard, M.D.

Lorriana Leard, M.D.

  • Associate Professor of Clinical Medicine
  • Division of Pulmonary & Critical Care Medicine
  • Department of Medicine
  • Associate Director, Pulmonary and Critical Care Medicine Fellowship

Contact Information

Academic Office
505 Parnassus Avenue, Moffitt 1336B, Box 0111
San Francisco, California 94143
Phone: 415-476-8287
Fax: 415-476-5712
[email protected]
Open Popup

Education

Stanford University, 1993
UC San Diego School of Medicine, 1998

Residencies

  • University of Texas Southwestern Medical Center, Internal Medicine, 2001

Fellowships

  • Pulmonary & Critical Care Medicine, UCSF, 2005
  • Lung Transplantation, UCSF, 2006

Board Certifications

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine -  Critical Care Medicine
  • American Board of Internal Medicine - Pulmonary Disease

Program Affiliations

  • Thoracic Oncology Progam
  • Lung Transplant Program
  • Lung Cancer Screening Program

Clinical Expertise

Research Interests

  • Complications of Lung Transplantation
  • Lung Cancer Screening & Surveillance

Biography

Lorriana Leard, MD is an Associate Professor of Clinical Medicine and a board-certified pulmonologist who specializes in the care of patients with lung cancer and advanced lung diseases who are candidates for lung transplants. As an expert at the UCSF Helen Diller Family Comprehensive Cancer Center, she evaluates patients who have lung nodules, lung masses or symptoms suggestive of lung cancer, and she helped to establish the Lung Cancer Screening Program at UCSF. She also performs advanced bronchoscopic procedures, including Endobronchial Ultrasound (EBUS), tracheobronchial dilatation, tracheal and bronchial stent placement, transbronchial needle aspiration and biopsies, and gold fiducial placement in preparation for Cyberknife therapy.

Dr. Leard received her undergraduate degree from Stanford University and her M.D. from the University of California San Diego. After completing her Internal Medicine residency at the University of Texas Southwestern in Dallas, she came to the University of California San Francisco for her Pulmonary and Critical Care Fellowship. She completed an additional subspecialty fellowship in Lung Transplantation at the University of California San Francisco and joined the faculty in 2006.

Her major academic interests include Lung Transplantation, Interventional Bronchoscopy, and Lung Cancer. She cares for patients on the Lung Transplant service, and at the UCSF Helen Diller Comprehensive Cancer Center at Mt. Zion.

UCSF Lung Cancer Screening Program offers same day low-dose CT scan and consultation with a pulmonologist. The process of being screened for lung cancer is explained in this video by Dr. Lorriana Leard

Awards & Honors

  Award  
  Confired By    
  Date    
  • V. Courtney Broaddus Award for Leadership and Service
  • UCSF
  • 2022
  • Academy of Medical Educators
  • UCSF
  • 2011
  • Michael S. Stulbarg Outstanding Teaching Award
  • UCSF
  • 2007

    • Research Overview

    Dr. Leard's current research interests include (1) Assessment of the role of Donor Specific Antibodies in the development of Bronchiolitis obliterans, (2) Bronchoscopy Complications, and (3) Lung Cancer Screening.

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 66
    Data provided by UCSF Profiles, powered by CTSI
    1. Santos J, Wang P, Shemesh A, Liu F, Tsao T, Aguilar OA, Cleary SJ, Singer JP, Gao Y, Hays SR, Golden J, Leard LE, Kleinhenz ME, Kolaitis NA, Shah RJ, Venado A, Kukreja J, Weigt SS, Belperio JA, Lanier LL, Looney MR, Greenland JR, Calabrese DR. CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury. JCI Insight. 2023 Oct 03. View in PubMed
    2. Santos J, Hays SR, Golden JA, Calabrese DR, Kolaitis N, Kleinhenz ME, Shah R, Estrada AV, Leard LE, Kukreja J, Singer JP, Greenland JR. Decreased Lymphocytic Bronchitis Severity in the Era of Azithromycin Prophylaxis. Transplant Direct. 2023 Sep; 9(9):e1495. View in PubMed
    3. Singer JP, Christie JD, Diamond JM, Anderson MA, Benvenuto LA, Gao Y, Arcasoy SM, Lederer DJ, Calabrese D, Wang P, Hays SR, Kukreja J, Venado A, Kolaitis NA, Leard LE, Shah RJ, Kleinhenz ME, Golden J, Betancourt L, Oyster M, Zaleski D, Adler J, Kalman L, Balar P, Patel S, Medikonda N, Koons B, Tevald M, Covinsky KE, Greenland JR, Katz PK. Development of the Lung Transplant Frailty Scale (LT-FS). J Heart Lung Transplant. 2023 Jul; 42(7):892-904. View in PubMed
    4. Odisho AY, Liu AW, Maiorano AR, Bigazzi MOA, Medina E, Leard LE, Shah R, Venado A, Perez A, Golden J, Kleinhenz ME, Kolaitis NA, Maheshwari J, Trinh BN, Kukreja J, Greenland J, Calabrese D, Neinstein AB, Singer JP, Hays SR. Design and implementation of a digital health home spirometry intervention for remote monitoring of lung transplant function. J Heart Lung Transplant. 2023 06; 42(6):828-837. View in PubMed
    5. Calabrese DR, Chong T, Singer JP, Rajalingam R, Hays SR, Kukreja J, Leard L, Golden JA, Lanier LL, Greenland JR. CD16+ natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction. Am J Transplant. 2023 01; 23(1):37-44. View in PubMed
    6. View All Publications

     

     
    Site Directory
      X